Christopher J Tyler1,2, Tamara Pérez-Jeldres1,2,3, Erik Ehinger4, Brian Capaldo5, Thangaraj Karuppuchamy1,2, Joshua D Boyer1,2, Derek Patel2, Parambir Dulai1,2, Brigid S Boland1, Joanne Lannigan5, Lars Eckmann1, Peter B Ernst6,7, William J Sandborn2, Samuel B Ho1,2, Jesús Rivera-Nieves1,2. 1. Inflammatory Bowel Disease Center, Division of Gastroenterology, University of California San Diego, La Jolla, California. 2. VA San Diego Healthcare System, San Diego, California. 3. Universidad Catolica de Chile, Santiago, Chile. 4. Flow Cytometry Core Facility, La Jolla Institute of Allergy and Immunology, La Jolla, California. 5. Flow Cytometry Core Facility, University of Virginia, Charlottesville, Virginia. 6. Division of Comparative Pathology, Department of Pathology, University of California San Diego, La Jolla, California. 7. Chiba University-UC San Diego Program in Mucosal Immunology, Allergy and Vaccines, San Diego, California.
Abstract
Background: Novel therapeutics for inflammatory bowel disease (IBD) are under development, yet mechanistic readouts at the tissue level are lacking. Techniques to assess intestinal immune composition could represent a valuable tool for mechanism of action (MOA) studies of novel drugs. Mass cytometry enables analysis of intestinal inflammatory cell infiltrate and corresponding molecular fingerprints with unprecedented resolution. Here, we aimed to optimize the methodology for isolation and cryopreservation of cells from intestinal tissue to allow for the potential implementation of mass cytometry in MOA studies. Methods: We investigated key technical issues, including minimal tissue requirements, cell isolation protocols, and cell storage, using intestinal biopsies and peripheral blood from healthy individuals. High-dimensional mass cytometry was employed for the analyses of biopsy-derived intestinal cellular subsets. Results: Dithiothreitol and mechanical dissociation decreased epithelial cell contamination and allowed for isolation of adequate cell numbers from 2 to 4 colonic or ileal biopsies (6 × 104±2 × 104) after a 20-minute collagenase digestion, allowing for reliable detection of most major immune cell subsets. Biopsies and antibody-labeled mononuclear cells could be cryopreserved for later processing and acquisition (viability > 70%; P < 0.05). Conclusions: Mass cytometry represents a unique tool for deep immunophenotyping intestinal cell composition. This technique has the potential to facilitate analysis of drug actions at the target tissue by identifying specific cellular subsets and their molecular signatures. Its widespread implementation may impact not only IBD research but also other gastrointestinal conditions where inflammatory cells play a role in pathogenesis.
Background: Novel therapeutics for inflammatory bowel disease (IBD) are under development, yet mechanistic readouts at the tissue level are lacking. Techniques to assess intestinal immune composition could represent a valuable tool for mechanism of action (MOA) studies of novel drugs. Mass cytometry enables analysis of intestinal inflammatory cell infiltrate and corresponding molecular fingerprints with unprecedented resolution. Here, we aimed to optimize the methodology for isolation and cryopreservation of cells from intestinal tissue to allow for the potential implementation of mass cytometry in MOA studies. Methods: We investigated key technical issues, including minimal tissue requirements, cell isolation protocols, and cell storage, using intestinal biopsies and peripheral blood from healthy individuals. High-dimensional mass cytometry was employed for the analyses of biopsy-derived intestinal cellular subsets. Results: Dithiothreitol and mechanical dissociation decreased epithelial cell contamination and allowed for isolation of adequate cell numbers from 2 to 4 colonic or ileal biopsies (6 × 104±2 × 104) after a 20-minute collagenase digestion, allowing for reliable detection of most major immune cell subsets. Biopsies and antibody-labeled mononuclear cells could be cryopreserved for later processing and acquisition (viability > 70%; P < 0.05). Conclusions: Mass cytometry represents a unique tool for deep immunophenotyping intestinal cell composition. This technique has the potential to facilitate analysis of drug actions at the target tissue by identifying specific cellular subsets and their molecular signatures. Its widespread implementation may impact not only IBD research but also other gastrointestinal conditions where inflammatory cells play a role in pathogenesis.
Authors: Yi Yao; Rebecca Liu; Min Sun Shin; Mark Trentalange; Heather Allore; Ala Nassar; Insoo Kang; Jordan S Pober; Ruth R Montgomery Journal: J Immunol Methods Date: 2014-11-04 Impact factor: 2.303
Authors: Evan W Newell; Natalia Sigal; Nitya Nair; Brian A Kidd; Harry B Greenberg; Mark M Davis Journal: Nat Biotechnol Date: 2013-06-09 Impact factor: 54.908
Authors: Ligia A Pinto; Matthew T Trivett; Dora Wallace; Jeanette Higgins; Michael Baseler; Masaki Terabe; Igor M Belyakov; Jay A Berzofsky; Allan Hildesheim Journal: Cytometry B Clin Cytom Date: 2005-01 Impact factor: 3.058
Authors: Michael Thomas Wong; David Eng Hui Ong; Frances Sheau Huei Lim; Karen Wei Weng Teng; Naomi McGovern; Sriram Narayanan; Wen Qi Ho; Daniela Cerny; Henry Kun Kiaang Tan; Rosslyn Anicete; Bien Keem Tan; Tony Kiat Hon Lim; Chung Yip Chan; Peng Chung Cheow; Ser Yee Lee; Angela Takano; Eng-Huat Tan; John Kit Chung Tam; Ern Yu Tan; Jerry Kok Yen Chan; Katja Fink; Antonio Bertoletti; Florent Ginhoux; Maria Alicia Curotto de Lafaille; Evan William Newell Journal: Immunity Date: 2016-08-09 Impact factor: 31.745
Authors: Peng Qiu; Erin F Simonds; Sean C Bendall; Kenneth D Gibbs; Robert V Bruggner; Michael D Linderman; Karen Sachs; Garry P Nolan; Sylvia K Plevritis Journal: Nat Biotechnol Date: 2011-10-02 Impact factor: 54.908
Authors: Martin Guilliams; Charles-Antoine Dutertre; Charlotte L Scott; Naomi McGovern; Dorine Sichien; Svetoslav Chakarov; Sofie Van Gassen; Jinmiao Chen; Michael Poidinger; Sofie De Prijck; Simon J Tavernier; Ivy Low; Sergio Erdal Irac; Citra Nurfarah Mattar; Hermi Rizal Sumatoh; Gillian Hui Ling Low; Tam John Kit Chung; Dedrick Kok Hong Chan; Ker Kan Tan; Tony Lim Kiat Hon; Even Fossum; Bjarne Bogen; Mahesh Choolani; Jerry Kok Yen Chan; Anis Larbi; Hervé Luche; Sandrine Henri; Yvan Saeys; Evan William Newell; Bart N Lambrecht; Bernard Malissen; Florent Ginhoux Journal: Immunity Date: 2016-09-13 Impact factor: 31.745